Arizona State Retirement System Buys 87 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Arizona State Retirement System boosted its stake in shares of Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 2.0% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,543 shares of the company’s stock after buying an additional 87 shares during the quarter. Arizona State Retirement System’s holdings in Addus HomeCare were worth $527,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Boston Partners bought a new stake in Addus HomeCare during the 1st quarter valued at $12,215,000. Lord Abbett & CO. LLC bought a new stake in shares of Addus HomeCare in the first quarter valued at about $8,274,000. Principal Financial Group Inc. lifted its stake in Addus HomeCare by 20.9% in the second quarter. Principal Financial Group Inc. now owns 430,444 shares of the company’s stock worth $49,979,000 after acquiring an additional 74,488 shares during the period. Allianz Asset Management GmbH bought a new position in Addus HomeCare during the 4th quarter worth about $5,667,000. Finally, Janus Henderson Group PLC increased its position in Addus HomeCare by 683.7% during the 1st quarter. Janus Henderson Group PLC now owns 55,188 shares of the company’s stock valued at $5,703,000 after purchasing an additional 48,146 shares during the period. 95.35% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the company’s stock in a transaction on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at approximately $961,687.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, Director Esteban Lopez sold 500 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $130.03, for a total transaction of $65,015.00. Following the sale, the director now directly owns 3,866 shares of the company’s stock, valued at $502,695.98. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total transaction of $2,921,316.93. Following the sale, the executive vice president now directly owns 7,215 shares in the company, valued at $961,687.35. The disclosure for this sale can be found here. Insiders have sold 22,917 shares of company stock valued at $3,050,082 in the last ninety days. Insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently commented on ADUS shares. TD Cowen boosted their price target on shares of Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. StockNews.com lowered shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Sunday, July 7th. Oppenheimer boosted their price objective on shares of Addus HomeCare from $130.00 to $140.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $141.00 price objective on shares of Addus HomeCare in a research note on Tuesday, September 3rd. Finally, Stephens reiterated an “overweight” rating and set a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. One investment analyst has rated the stock with a sell rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $127.57.

Read Our Latest Analysis on Addus HomeCare

Addus HomeCare Trading Up 1.4 %

NASDAQ:ADUS opened at $132.00 on Tuesday. The company has a market cap of $2.39 billion, a PE ratio of 32.75, a P/E/G ratio of 2.33 and a beta of 1.04. Addus HomeCare Co. has a twelve month low of $78.35 and a twelve month high of $134.78. The company’s 50 day moving average is $125.77 and its two-hundred day moving average is $113.00.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its quarterly earnings data on Monday, August 5th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14. The business had revenue of $286.90 million for the quarter, compared to the consensus estimate of $284.90 million. Addus HomeCare had a net margin of 6.18% and a return on equity of 9.81%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm earned $0.94 EPS. As a group, analysts expect that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.